Katarina Sjögreen Gleisner
21 – 30 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Peptide Receptor Radionuclide Therapy – Prospects for Personalised Treatment
(
- Contribution to journal › Article
-
Mark
Pituitary function after high-dose 177Lu-DOTATATE therapy and long-term follow-up
(
- Contribution to journal › Article
- 2020
-
Mark
Characterisation of a hand-held CZT-based gamma camera for 177Lu imaging
(
- Contribution to journal › Article
- 2019
-
Mark
Analysis of activity uptake, effective half-life and time-integrated activity for low- and high-risk papillary thyroid cancer patients treated with 1.11 GBq and 3.7 GBq of 131I-NaI respectively
(
- Contribution to journal › Article
-
Mark
Re : Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma
(
- Contribution to journal › Letter
-
Mark
Bone marrow absorbed doses and correlations with hematological response during 177Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases
(
- Contribution to journal › Article
- 2018
-
Mark
Inter-comparison of quantitative imaging of lutetium-177 (177Lu) in European hospitals
(
- Contribution to journal › Article
-
Mark
3-D Image-Based Dosimetry in Radionuclide Therapy
(
- Contribution to journal › Scientific review
-
Mark
A method for tumor dosimetry based on hybrid planar-SPECT/CT images and semiautomatic segmentation
(
- Contribution to journal › Article
-
Mark
EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
(
- Contribution to journal › Article